Oral Abstract: ABCL-360: Glofitamab Step-Up Dosing (SUD): Updated Efficacy Data Show High Complete Response Rates in Heavily Pretreated Relapsed/Refractory (R/R) Non-Hodgkin Lymphoma (NHL) Patients (Pts)

https://doi.org/10.1016/S2152-2650(21)01279-9Get rights and content

References (0)

Cited by (0)

View full text